Predictors of High Defibrillation Threshold in Patients With Implantable Cardioverter-Defibillator Using a Transvenous Dual-Coil Lead
-
- Mizukami Kazuya
- Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
- Yokoshiki Hisashi
- Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
- Mitsuyama Hirofumi
- Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
- Watanabe Masaya
- Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
- Tenma Taro
- Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
- Matsui Yoshiro
- Department of Cardiovascular Surgery, Hokkaido University Graduate School of Medicine
-
- Tsutsui Hiroyuki
- Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
この論文をさがす
抄録
Background:Defibrillation testing (DT) is considered a standard procedure during implantable cardioverter-defibrillator (ICD) implantation. However, little is known about the factors that are significantly related to patients with high defibrillation threshold (DFT) using the present triad system.Methods and Results:We examined 286 consecutive patients who underwent ICD implantation with a transvenous dual-coil lead and DT from December 2000 to December 2011. We defined patients who required 25 J or more by the implanted device as the high DFT group, and those who required less than 25 J as the normal DFT group. For each patient, assessment parameters included underlying disease, comorbidities, NYHA functional class, drugs, and echocardiographic measures. The high DFT group consisted of 12 patients (4.2%). Multivariate analysis identified 3 independent predictors for high DFT: atrial fibrillation (odds ratio (OR) 4.85, 95% confidence interval (CI) 1.24–22.33, P=0.023), hypertension (OR 4.01, 95% CI 1.08–15.96, P=0.039), thickness of interventricular septum (IVS) >12 mm (OR 4.82, 95% CI 1.17–20.31, P=0.030).Conclusions:Atrial fibrillation, hypertension and IVS hypertrophy were significantly associated with high DFT. Identification of such patients could help to lower the risk of complications with DT. (Circ J 2015; 79: 77–84)
収録刊行物
-
- Circulation Journal
-
Circulation Journal 79 (1), 77-84, 2014
一般社団法人 日本循環器学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282680083615872
-
- NII論文ID
- 40020311789
- 130004704024
-
- NII書誌ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 026000823
-
- PubMed
- 25391259
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可